secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001437749-24-017648
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed names William Elder as CFO; William Tanner departs to consulting role
------------------------------------------------------------------------------

- William Elder appointed CFO effective June 1, 2024, succeeding William Tanner; Elder continues as General Counsel and Corporate Secretary.
- Outgoing CFO William Tanner to serve as consultant through Dec 2025; receives $162,000 severance plus prorated bonus and extended stock option vesting.
- Elder's compensation: base salary $429,000, target bonus 35% of base; severance includes 9 months salary on non-cause termination.
- Company expects RewinD-LB Phase 2b enrollment completion in Q2 2024, topline efficacy results in Q4 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/0001437749-24-017648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/crvo20240520_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-017648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer